Effect of Transcutaneous Electrical Acupoint Stimulation on Obstetric Quality of Recovery-10 After Cesarean Section

The primary aim of this prospective and randomized trial is to investigate the effect of TEAS on postoperative recovery using the Obstetric Quality of Recovery-10 questionnaire in patients undergoing elective cesarean section.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Recovery

Age range

18 year–48 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Betul Kozanhan

Konya, 42005, Turkey (Türkiye)

About this study

Acupoint stimulation is postulated to modulate neurological signal transmission through afferent nociceptive pathways. Acupoint stimulation has been associated with positive effects on perioperative symptoms such as nausea, pain, and sleep disturbance. Transcutaneous electrical acupuncture point stimulation (TEAS) is an acupuncture treatment developed by combining traditional Chinese acupuncture with transcutaneous electrical nerve stimulation. TEAS has proven to be effective in postoperative pain and nausea-vomiting by applying a current of different frequencies, intensities, and waveforms through electrodes adhering to the skin. Using TEAS may relieve perioperative symptoms without increasing the risk of drug-related adverse events and alleviate and improve the patient's health condition, including the postoperative perspective.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Elective cesarean operation
Able to give informed consent

Exclusion criteria

Patients with neurological or psychological diseases
patients with chronic analgesic and antidepressant drug use
Patients unable to communicate
Patients previously treated with TEAS or acupuncture,
Patients with heart failure and have pace-maker,
patient with local infection in the TEAS area

Treatment and study plan

Transcutaneous electrical acupoint stimulation

Device

Transcutaneous Electrical Acupoint Stimulation

Primary outcomes

Quality of Recovery

Time frame: The first 24 hours postoperatively

Obstetric Quality of Recovery-10 (ObsQoR-10©) Scoring Tool

Sponsors and collaborators

Lead sponsor

Konya Meram State Hospital

Other

Registry information

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2022
First posted: Jun 8, 2021
Registry last updated: Sep 25, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed